Bluejay Diagnostics (BJDX) Total Liabilities (2022 - 2023)
Bluejay Diagnostics (BJDX) has disclosed Total Liabilities for 2 consecutive years, with $3.0 million as the latest value for Q3 2023.
- Quarterly Total Liabilities rose 60.11% to $3.0 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Sep 2023, up 60.11% year-over-year, with the annual reading at $2.0 million for FY2022, N/A changed from the prior year.
- Total Liabilities hit $3.0 million in Q3 2023 for Bluejay Diagnostics, up from $2.1 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $3.0 million in Q3 2023 to a low of $1.4 million in Q2 2022.